CN101028492B - Chinese preparation for treating hysteromyoma - Google Patents
Chinese preparation for treating hysteromyoma Download PDFInfo
- Publication number
- CN101028492B CN101028492B CN2007100654867A CN200710065486A CN101028492B CN 101028492 B CN101028492 B CN 101028492B CN 2007100654867 A CN2007100654867 A CN 2007100654867A CN 200710065486 A CN200710065486 A CN 200710065486A CN 101028492 B CN101028492 B CN 101028492B
- Authority
- CN
- China
- Prior art keywords
- parts
- vinegar
- stir
- treatment
- hysteromyoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010046798 Uterine leiomyoma Diseases 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims description 15
- 239000003814 drug Substances 0.000 claims abstract description 44
- 239000000052 vinegar Substances 0.000 claims description 45
- 235000021419 vinegar Nutrition 0.000 claims description 45
- 238000011282 treatment Methods 0.000 claims description 27
- 241000283956 Manis Species 0.000 claims description 17
- 241001489978 Eupolyphaga Species 0.000 claims description 14
- 239000009636 Huang Qi Substances 0.000 claims description 14
- 239000008517 radix Trichosanthis Substances 0.000 claims description 14
- 239000002994 raw material Substances 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 5
- 239000000463 material Substances 0.000 abstract description 2
- 241000131329 Carabidae Species 0.000 abstract 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 abstract 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract 1
- 240000009138 Curcuma zedoaria Species 0.000 abstract 1
- 241000233932 Sparganium Species 0.000 abstract 1
- 235000017803 cinnamon Nutrition 0.000 abstract 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 abstract 1
- 235000019509 white turmeric Nutrition 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 23
- 239000008280 blood Substances 0.000 description 21
- 210000004369 blood Anatomy 0.000 description 20
- 230000000694 effects Effects 0.000 description 19
- 239000000843 powder Substances 0.000 description 13
- 239000000796 flavoring agent Substances 0.000 description 11
- 235000019634 flavors Nutrition 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 10
- 230000001737 promoting effect Effects 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 208000029312 Muscular tumor Diseases 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 238000001035 drying Methods 0.000 description 7
- 201000000736 Amenorrhea Diseases 0.000 description 6
- 206010001928 Amenorrhoea Diseases 0.000 description 6
- 231100000540 amenorrhea Toxicity 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 206010000087 Abdominal pain upper Diseases 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 239000006196 drop Substances 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 206010019847 hepatosplenomegaly Diseases 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 229940023488 pill Drugs 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 210000001550 testis Anatomy 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229940046011 buccal tablet Drugs 0.000 description 2
- 239000006189 buccal tablet Substances 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- -1 orally tuck in Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- LAOOXBLMIJHMFO-UHFFFAOYSA-N 1-[2-(diethylamino)ethylamino]-4-methylthioxanthen-9-one;hydron;chloride Chemical compound Cl.S1C2=CC=CC=C2C(=O)C2=C1C(C)=CC=C2NCCN(CC)CC LAOOXBLMIJHMFO-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 206010039587 Scarlet Fever Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000035508 accumulation Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- NKWPZUCBCARRDP-UHFFFAOYSA-L calcium bicarbonate Chemical compound [Ca+2].OC([O-])=O.OC([O-])=O NKWPZUCBCARRDP-UHFFFAOYSA-L 0.000 description 1
- 229910000020 calcium bicarbonate Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000002662 enteric coated tablet Substances 0.000 description 1
- 230000001856 erectile effect Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 230000005986 heart dysfunction Effects 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 206010020488 hydrocele Diseases 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 201000010260 leiomyoma Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 208000018299 prostration Diseases 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 230000001843 schistosomicidal effect Effects 0.000 description 1
- 210000004999 sex organ Anatomy 0.000 description 1
- 150000003376 silicon Chemical class 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000027849 smooth muscle hyperplasia Effects 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Abstract
A Chinese medicine for treating hysteromyoma is prepared from more than 10 Chinese-medicinal materials including burreed tuber, zedoary, ground beetle, cinnamon twig, etc.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation for the treatment of hysteromyoma, is that a kind of hysteromyoma for the treatment of is the Chinese patent medicine of raw material with the Chinese herbal medicine.Belong to the field of Chinese medicines.
Background technology
Hysteromyoma is a modal benign tumor in the female sex organ.Its definite diagnosis forms by uterine smooth muscle hyperplasia, wherein contains a spot of fibrous connective tissue, but be not to be the element of muscular tumor, so should be " leiomyoma of uterus " common name " hysteromyoma ".The clinical manifestation of hysteromyoma often has or not secondary degeneration and complication etc. with muscular tumor growth site, size, the speed of growth and is different, many clinically patients are asymptomatic, only idol is found when pelvioscopy, and it is metrorrhagia, abdominal mass, pain, adjacent organs pressure symptom, leucorrhoea grow in quantity, infertile, secondary anemia and heart dysfunction etc. that 20%～50% muscular tumor common sympton is arranged approximately.The difficult statistics of the incidence rate of hysteromyoma, a lot of patients are because of asymptomatic or because of the less clinical difficult discovery of muscular tumor.Hysteromyoma is more common in 30～50 years old women, has 20% women that hysteromyoma is arranged approximately, and women's sickness rate of 40～50 years old is the highest.Hysteromyoma belongs to the traditional Chinese medical science " stony mass of uterus " category.
The traditional Chinese medical science thinks that stopping in the blood stasis is the pathogenesis key of primary disease, so method of treatment is abided by " hard masses should be resolved gradually; diseases with invaded pathogens should be treated by expelling; disease caused by accumulations of pathogen should be treated with therapy of dispersion; disease with retention of pathogen in the body should be treated by elimination therapy " that " element ask the most pure virginity will discuss greatly " proposes more, the method for " can make removing mass, can make the heavily fortified point of bursting ", adopting blood circulation promoting and blood stasis dispelling, removing mass Xiao Disorder is major-minorly to invigorate blood circulation or rush down the removing blood stasis or the methods such as mending combination that disappears down so that temperature is logical.Be divided into clinically: stop strongly fragrant and heat-transformation in the blood stasis; Cold blood stasis; Qi depression to blood stasis; Phlegm and blood stasis; The dialectical treatments of disease type such as blood stasis due to qi deficiency obtain better curative effect.At present, western medical treatment mainly adopts operative treatment, brings very heavy mental burden and financial burden for patient and household, and side effect is in various degree arranged.
Summary of the invention
The present invention develops in conjunction with the latest modern technological scientific achievement on the basis of traditional tcm syndrome differentiation and treatment.The purpose of this invention is to provide a kind of Chinese medicine preparation for the treatment of hysteromyoma.Have determined curative effect, safe ready, have no side effect, cheap characteristics.
The present invention is made by the following weight proportion raw material:
0.1～2 part of 1.5～6 parts of vinegar Squama Manis of 1.5～6 parts of stir-baked RHIIZOMA CURCUMAE with vinegar of stir-baked RHIZOMA SPARGANII with vinegar
1～4 part of 1.5～6 parts of Herba Epimedii Preparata of 0.1～2 part of Radix Astragali of Eupolyphaga Seu Steleophaga
0.1～2 part of 1.5～6 parts of Fructus Foeniculi (parched) of 0.1～2 part of Radix Trichosanthis of Bulbus Fritillariae Thunbergii
0.1～2 part of Ramulus Cinnamomi
The weight proportion of each raw material of optimization formula of the present invention is:
0.5～1.5 part of 2.5～3.5 parts of vinegar Squama Manis of 2.5～3.5 parts of stir-baked RHIIZOMA CURCUMAE with vinegar of stir-baked RHIZOMA SPARGANII with vinegar
1.5～2.5 parts of 2.5～3.5 parts of Herba Epimedii Preparata of 0.5～1.5 part of Radix Astragali of Eupolyphaga Seu Steleophaga
0.5～1.5 part of 2.5～3.5 parts of Fructus Foeniculi (parched) of 0.5～1.5 part of Radix Trichosanthis of Bulbus Fritillariae Thunbergii
0.5～1.5 part of Ramulus Cinnamomi
The weight proportion of each raw material of optimum formula of the present invention is:
1 part of 3 parts of vinegar Squama Manis of 3 parts of stir-baked RHIIZOMA CURCUMAE with vinegar of stir-baked RHIZOMA SPARGANII with vinegar
2 parts of 3 parts of Herba Epimedii Preparata of 1 part of Radix Astragali of Eupolyphaga Seu Steleophaga
1 part of 3 parts of Fructus Foeniculi (parched) of 1 part of Radix Trichosanthis of Bulbus Fritillariae Thunbergii
1 part of Ramulus Cinnamomi
Drug action mechanism among the present invention is as follows:
Stir-baked RHIZOMA SPARGANII with vinegar nature and flavor suffering, hardship, flat.Return liver, spleen channel.Has removing blood stasis, circulation of qi promoting, removing food stagnancy analgesic effect.Ke Zhi Liao lumps in the chest and abdomen, coagulation of QI-blood, trusted subordinate's pain, the food stagnation distending pain, the side of body expands painful down, amenorrhea, dysmenorrhea, postnatal blood stasis stomachache, traumatic injury, skin ulcer is swollen hard, hepatosplenomegaly etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 69th page).
Stir-baked RHIIZOMA CURCUMAE with vinegar nature and flavor hardship, suffering, temperature.Return liver, spleen channel.Have the circulation of qi promoting removing blood stasis with potent drugs, the removing food stagnancy pain relieving is changed poly-eliminating mass, the effect of antiearly pregnancy.Can treat that trusted subordinate's distending pain, lump in the abdomen, dyspepsia do not disappear, hepatosplenomegaly, abdominal pain due to blood stasis, amenorrhea due to stagnation of blood, cervical erosion, traumatic injury have a pain etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 995th page).
The Eupolyphaga Seu Steleophaga nature and flavor are salty, cold, slightly poisonous.Return Liver Channel.Has promoting blood circulation to remove blood stasis, inducing menstruation to relieve menalgia, the abdominal mass that disappears, the effect of reunion of bone.Ke Zhi Liao lumps in the chest and abdomen, amenorrhea due to stagnation of blood, postnatal blood stasis stomachache, traumatic injury, swollen and rigid tongue, congenital deformity of the tongue, the muscles and bones folding is hindered hepatosplenomegaly, an emaciation due to blood disorder, scarlet fever, erysipelas etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 91st page).
Vinegar Squama Manis nature and flavor are salty, cool, be slightly cold.Return liver, stomach warp.Has detumescence and apocenosis, dredging collateral for promoting lactation, promoting blood circulation and stopping pain, the effect of removing food stagnancy.Carbuncle sore tumefacting virus be can control and stain, galactostasis, anemofrigid-damp arthralgia, amenorrhea, infantile malnutrition stomachache, dyspepsia, traumatic hemorrhage, hematuria, the tuberculosis of cervical lymph nodes etc. become from the beginning of, pus.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 956th page).
The Radix Astragali nature and flavor are sweet, warm.Return lung, spleen channel.Have benefit and defend consolidating superficial resistance, inducing diuresis to remove edema, poison holding, the effect of granulation promoting.That can treat that internal injury overstrain, diarrhea due to hypofunction of the spleen, proctoptosis, deficiency of vital energy blood prostration, metrorrhagia and leukorrhagia, spontaneous perspiration, night sweat, arthralgia due to stagnation of blood, edema, carbuncle do not burst or burst does not hold back and the disease of all weakness of QI blood deficiency etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 1074th page).
Herba Epimedii Preparata nature and flavor suffering, sweet, warm.Return liver, kidney channel.Effect with kidney invigorating and YANG supporting, expelling wind and removing dampness, bone and muscle strengthening.Can treat that sexual impotence erectile problem, dribbling urination, muscles and bones contraction urgency, hemiplegia, weakness of the waist and knees, rheumatic arthralgia, extremity are meciless, climacteric hypertension disease, Mental fatigue are forgetful, neurasthenia, osteomyelitis etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 1143rd page).
The big hardship of Bulbus Fritillariae Thunbergii nature and flavor, cold in nature.Return lunar, the few sun of hands, bright, the JUE YIN meridian of foot sun.Has the transconversion into heat of disappearing expectorant, the effect of detoxicating and resolving stagnation of pathogens.Can treat the cough due to pathogenic wind-heat, lung abscess sore throat, scrofula, sore swollen toxin etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 1029th page).
Sweet, the little hardship of Radix Trichosanthis nature and flavor, be slightly cold.Attach to the lung and stomach meridians.Has clearing away heat and promoting production of body fluid, the effect of detumescence and apocenosis.Can treat the calentura excessive thirst, lung-heat type cough, interior-heat is quenched one's thirst, jaundice, sore swollen toxin, hemorrhoid complicated by anal fistula etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 243rd page).
Fructus Foeniculi (parched) nature and flavor suffering, temperature.Return liver,kidney,spleen, stomach, urinary bladder channel.Has dispersing cold for relieving pain, the effect of regulating qi-flowing for harmonizing stomach.Can treat cold syndrome of the stomach bitterly, colic of cold type stomachache, testis swelling and hanging down of either of the testes pain, few abdomen cold type of pain, abdominal distention, dyspepsia, lack of appetite and vomiting, hydrocele of testis, schistosomicide, lumbago due to renal deficiency, vomiting, dried, beriberi caused by pathogenic damp, asthma etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 206th page)
Ramulus Cinnamomi nature and flavor suffering, sweet, warm.GUIXIN, bladder, lung meridian.Has the diaphoresis expelling pathogenic factors from muscles, warming the meridian and promoting blood circulation, the cold-damp of dispeling the wind, the horizontal logical podomere of row upper limb, activating YANG and prormoting functioning of QI, the effect of the flat gas that spins.Can treat exterior syndrome due to wind-cold, shoulder back of the body podomere is ached, thoracic obstruction phlegm retention, amenorrhea lump in the abdomen, rheumatic arthralgia, cold, cough with asthma phlegm retention, amenorrhea stomachache etc.(Ji Yubin chief editor " Chinese medicine medicine for preventing pharmacology and application " Heilungkiang science tech publishing house 1999 version the 980th page).
The present invention follows the principles of formulating prescriptions of the traditional Chinese medical science " monarch ", is monarch with stir-baked RHIZOMA SPARGANII with vinegar, stir-baked RHIIZOMA CURCUMAE with vinegar, Eupolyphaga Seu Steleophaga and vinegar Squama Manis; Radix Astragali, Herba Epimedii Preparata, Bulbus Fritillariae Thunbergii and Radix Trichosanthis are minister; Fructus Foeniculi (parched) and Ramulus Cinnamomi make for assistant.All medicines are harmonious, altogether the effect of tool blood circulation promoting and blood stasis dispelling, Xiao Disorder eliminating stagnation.The treatment hysteromyoma has determined curative effect, has no side effect taking convenience, cheap characteristics.
Chinese medicine preparation of the present invention, can add the medicine acceptable carrier when being prepared into medicament, described medicine acceptable carrier can be: starch, sucrose, lactose, mannitol, silicon derivative, cellulose family and derivant thereof, alginate, gelatin, polyvinylpyrrolidone, glycerol, soil temperature 80, agar, calcium carbonate, calcium bicarbonate, surfactant, Polyethylene Glycol, cyclodextrin, beta-schardinger dextrin-, phospholipid material, Kaolin, Pulvis Talci, calcium stearate, magnesium stearate etc.
Chinese medicine preparation of the present invention can be any pharmaceutically useful dosage form, and these dosage forms comprise: tablet, sugar coated tablet, film coated tablet, enteric coated tablet, capsule, hard capsule, soft capsule, orally tuck in, buccal tablet, granule, pill, powder, unguentum, sublimed preparation, suspensoid, powder, solution, injection, suppository, ointment, plaster, cream, spray, drop, patch.
Preparation of the present invention, preferably peroral dosage form is as tablet, capsule, oral liquid, buccal tablet, granule, pill, powder, suspensoid, powder, solution, drop, drop pill.Preferred Chinese medicine preparation is capsule, tablet, granule.
Clinical drug of the present invention uses the result to show that following advantage is arranged:
1, the Chinese herbal medicine each component selected for use of the present invention meets the regulation of The Drug Administration Law of People's Republic of China, utilizes the comprehensive function treatment hysteromyoma of the Chinese medicine of respectively distinguishing the flavor of, and is nontoxic to human body.Show that through animal acute toxicity experiment the animal of being tested does not see any toxic reaction, its main organs does not have tangible change yet, and safety of medicine is reliable.
2, the present invention need not decoct, no bitterness sense, rich in proteins in the medicine, glucose, glucuronic acid, volatile oil, pectin, fructose, organic acid, lecithin, vitamin, aminoacid also contains various trace elements such as Saponin, plant sterol and calcium, is beneficial to absorption of human body, health invigorating.
3, the present invention treats hysteromyoma and has determined curative effect, has no side effect taking convenience, cheap characteristics.
Further specify the therapeutic effect of medicine of the present invention below by the clinical practice example to the treatment hysteromyoma.
The hysteromyoma curative effect determinate standard:
1, recovery from illness: muscular tumor disappears, clinical symptom disappearance.
2, produce effects: muscular tumor is dwindled more than 1/2, and the mild symptoms multiple integral reduces 〉=2/3 before the treatment.
3, effective: muscular tumor dwindles 1/3, and the mild symptoms multiple integral reduces 〉=1/3～2/3 before the treatment.
4, invalid: muscular tumor does not see obviously and dwindles that the mild symptoms multiple integral reduces less than 1/3 before the treatment.(Luo Yunjian etc. chief editor " gynecological's disease that calls for specialized treatment tcm clinical practice diagnosis and treatment " People's Health Publisher 2000 version the 450th page).
For showing the therapeutic effect of medicine of the present invention, as follows through clinical test results to the treatment hysteromyoma; Treatment patients with uterine myoma 32 examples, the age is 30～50 years old.Take embodiment 3 granules, each 1～3 bag, three to four times on the one, boiled water is taken after mixing it with water, and take half an hour ante cibum.One month is a course of treatment, take continuously three the course of treatment observe the curative effect.Cure 22 examples and account for 68.75%, produce effects 5 examples account for 15.6%, and effective 2 examples account for 6.25%, and invalid 3 examples account for 9.4%, and total effective rate reaches more than 90%.After three course of therapy, patient does not have any untoward reaction, and three big routine tests and hepatic and renal function detect no abnormal.
The specific embodiment
Embodiment 1 capsule takes by weighing raw material by following weight:
1 part of 3 parts of vinegar Squama Manis of 3 parts of stir-baked RHIIZOMA CURCUMAE with vinegar of stir-baked RHIZOMA SPARGANII with vinegar
2 parts of 3 parts of Herba Epimedii Preparata of 1 part of Radix Astragali of Eupolyphaga Seu Steleophaga
1 part of 3 parts of Fructus Foeniculi (parched) of 1 part of Radix Trichosanthis of Bulbus Fritillariae Thunbergii
1 part of Ramulus Cinnamomi
Preparation method is to get the vinegar Squama Manis earlier, Bulbus Fritillariae Thunbergii and Fructus Foeniculi (parched) drying and crushing to 120～200 order fine powders, get stir-baked RHIZOMA SPARGANII with vinegar again, stir-baked RHIIZOMA CURCUMAE with vinegar, Eupolyphaga Seu Steleophaga, Radix Astragali, Herba Epimedii Preparata, Radix Trichosanthis and Ramulus Cinnamomi decoct with water twice, 1.5～2 hours for the first time, 0.5～1 hour for the second time, merge decocting liquid twice, filter, filtrate is concentrated into 80 degree～85 when spending, the clear paste of relative density 1.08～1.10, adding ethanol makes clear paste contain the alcohol amount to reach 70%, left standstill 24 hours, and reclaimed ethanol, when 50 degree～55 are spent, be concentrated into the clear paste of relative density 1.30～1.32, again with clear paste and vinegar Squama Manis, Bulbus Fritillariae Thunbergii and Fructus Foeniculi (parched) fine powder mixing, drying is ground into fine powder, incapsulates.Adorn 0.3 gram for every, usually half an hour ante cibum oral, eliminating cold for resuscitation water send down, one time 2～10, three to four times on the one, one month is a course of treatment.
Embodiment 2 tablets take by weighing raw material by following weight:
1 part of 3 parts of vinegar Squama Manis of 3 parts of stir-baked RHIIZOMA CURCUMAE with vinegar of stir-baked RHIZOMA SPARGANII with vinegar
2 parts of 3 parts of Herba Epimedii Preparata of 1 part of Radix Astragali of Eupolyphaga Seu Steleophaga
1 part of 3 parts of Fructus Foeniculi (parched) of 1 part of Radix Trichosanthis of Bulbus Fritillariae Thunbergii
1 part of Ramulus Cinnamomi
Preparation method is to get the vinegar Squama Manis earlier, Bulbus Fritillariae Thunbergii and Fructus Foeniculi (parched) drying and crushing to 120～200 order fine powders, get stir-baked RHIZOMA SPARGANII with vinegar again, stir-baked RHIIZOMA CURCUMAE with vinegar, Eupolyphaga Seu Steleophaga, Radix Astragali, Herba Epimedii Preparata, Radix Trichosanthis and Ramulus Cinnamomi decoct with water twice, 1.5～2 hours for the first time, 0.5～1 hour for the second time, merge decocting liquid twice, filter, filtrate is concentrated into 80 degree～85 when spending, the clear paste of relative density 1.08～1.10, adding ethanol makes clear paste contain the alcohol amount to reach 70%, left standstill 24 hours, and reclaimed ethanol, when 50 degree～55 are spent, be concentrated into the clear paste of relative density 1.30～1.32, again with clear paste and vinegar Squama Manis, Bulbus Fritillariae Thunbergii and Fructus Foeniculi (parched) fine powder mixing, drying is ground into fine powder, adds appropriate amount of starch, alcohol granulation, after the drying, add an amount of magnesium stearate, tabletting, sugar coating are promptly.Usually half an hour ante cibum oral, eliminating cold for resuscitation water send down, one time 2～10, three to four times on the one, one month is a course of treatment.
Embodiment 3 granules take by weighing raw material by following weight:
1 part of 3 parts of vinegar Squama Manis of 3 parts of stir-baked RHIIZOMA CURCUMAE with vinegar of stir-baked RHIZOMA SPARGANII with vinegar
2 parts of 3 parts of Herba Epimedii Preparata of 1 part of Radix Astragali of Eupolyphaga Seu Steleophaga
1 part of 3 parts of Fructus Foeniculi (parched) of 1 part of Radix Trichosanthis of Bulbus Fritillariae Thunbergii
1 part of Ramulus Cinnamomi
Preparation method is to get the vinegar Squama Manis earlier, Bulbus Fritillariae Thunbergii and Fructus Foeniculi (parched) drying and crushing to 120～200 order fine powders, get stir-baked RHIZOMA SPARGANII with vinegar again, stir-baked RHIIZOMA CURCUMAE with vinegar, Eupolyphaga Seu Steleophaga, Radix Astragali, Herba Epimedii Preparata, Radix Trichosanthis and Ramulus Cinnamomi decoct with water twice, 1.5～2 hours for the first time, 0.5～1 hour for the second time, merge decocting liquid twice, filter, filtrate is concentrated into 80 degree～85 when spending, the clear paste of relative density 1.08～1.10 adds ethanol and makes clear paste contain the alcohol amount to reach 70%, left standstill 24 hours, reclaim ethanol, when spending, 50 degree～55 are concentrated into the clear paste of relative density 1.30～1.32, again with clear paste and vinegar Squama Manis, Bulbus Fritillariae Thunbergii and Fructus Foeniculi (parched) fine powder mixing, drying, be ground into fine powder, add an amount of sucrose and soluble starch, alcohol granulation, the pack of dry back is promptly.Usually half an hour ante cibum warm boiled water, one time 1～3 bag, three to four times on the one, one month is a course of treatment.
Claims (3)
1. Chinese medicine preparation for the treatment of hysteromyoma is characterized in that it is made by following raw materials by weight proportions:
0.1～2 part of 1.5～6 parts of vinegar Squama Manis of 1.5～6 parts of stir-baked RHIIZOMA CURCUMAE with vinegar of stir-baked RHIZOMA SPARGANII with vinegar
1～4 part of 1.5～6 parts of Herba Epimedii Preparata of 0.1～2 part of Radix Astragali of Eupolyphaga Seu Steleophaga
0.1～2 part of 1.5～6 parts of Fructus Foeniculi (parched) of 0.1～2 part of Radix Trichosanthis of Bulbus Fritillariae Thunbergii
0.1～2 part of Ramulus Cinnamomi.
2. a kind of Chinese medicine preparation for the treatment of hysteromyoma according to claim 1, wherein the weight proportion of each crude drug is:
0.5～1.5 part of 2.5～3.5 parts of vinegar Squama Manis of 2.5～3.5 parts of stir-baked RHIIZOMA CURCUMAE with vinegar of stir-baked RHIZOMA SPARGANII with vinegar
1.5～2.5 parts of 2.5～3.5 parts of Herba Epimedii Preparata of 0.5～1.5 part of Radix Astragali of Eupolyphaga Seu Steleophaga
0.5～1.5 part of 2.5～3.5 parts of Fructus Foeniculi (parched) of 0.5～1.5 part of Radix Trichosanthis of Bulbus Fritillariae Thunbergii
0.5～1.5 part of Ramulus Cinnamomi.
3. a kind of Chinese medicine preparation for the treatment of hysteromyoma according to claim 1, wherein the weight proportion of each crude drug is:
1 part of 3 parts of vinegar Squama Manis of 3 parts of stir-baked RHIIZOMA CURCUMAE with vinegar of stir-baked RHIZOMA SPARGANII with vinegar
2 parts of 3 parts of Herba Epimedii Preparata of 1 part of Radix Astragali of Eupolyphaga Seu Steleophaga
1 part of 3 parts of Fructus Foeniculi (parched) of 1 part of Radix Trichosanthis of Bulbus Fritillariae Thunbergii
1 part of Ramulus Cinnamomi.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007100654867A CN101028492B (en) | 2007-04-16 | 2007-04-16 | Chinese preparation for treating hysteromyoma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007100654867A CN101028492B (en) | 2007-04-16 | 2007-04-16 | Chinese preparation for treating hysteromyoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101028492A CN101028492A (en) | 2007-09-05 |
| CN101028492B true CN101028492B (en) | 2010-04-21 |
Family
ID=38714151
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2007100654867A Expired - Fee Related CN101028492B (en) | 2007-04-16 | 2007-04-16 | Chinese preparation for treating hysteromyoma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101028492B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104083717A (en) * | 2014-06-30 | 2014-10-08 | 韩凤娟 | Traditional Chinese medicine compound composition for treating ovarian cancer and application of composition |
| CN104208359A (en) * | 2014-08-22 | 2014-12-17 | 烟台瑞智生物医药科技有限公司 | Traditional Chinese medicine for treating toxic-heat stagnation type abdominal mass |
| CN105169206A (en) * | 2015-10-19 | 2015-12-23 | 烟台瑞智生物医药科技有限公司 | Traditional Chinese medicine for treating qi stagnation and blood stasis syndrome type abdominal mass |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1613481A (en) * | 2003-11-09 | 2005-05-11 | 黄双元 | Chinese patent drug for treating female ovarian cyst and its preparation |
| CN1634194A (en) * | 2003-12-30 | 2005-07-06 | 王卓然 | Genital disease treating Chinese medicine |
| CN1872324A (en) * | 2006-04-05 | 2006-12-06 | 张忠 | Medication for treating hysteromyoma |
-
2007
- 2007-04-16 CN CN2007100654867A patent/CN101028492B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1613481A (en) * | 2003-11-09 | 2005-05-11 | 黄双元 | Chinese patent drug for treating female ovarian cyst and its preparation |
| CN1634194A (en) * | 2003-12-30 | 2005-07-06 | 王卓然 | Genital disease treating Chinese medicine |
| CN1872324A (en) * | 2006-04-05 | 2006-12-06 | 张忠 | Medication for treating hysteromyoma |
Non-Patent Citations (3)
| Title |
|---|
| 刘习珍等.山甲三棱消瘤汤治疗子宫肌瘤66 例疗效观察.现代中西医结合杂志9 24.2000,9(24),第2480页-2481页. |
| 刘习珍等.山甲三棱消瘤汤治疗子宫肌瘤66 例疗效观察.现代中西医结合杂志9 24.2000,9(24),第2480页-2481页. * |
| 李祥云.中医妇科肿瘤的研究概况——李祥云教授妇科系列经验(12).辽宁中医杂志32 7.2005,32(7),第636页第1栏第3段-638页倒数第1段. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101028492A (en) | 2007-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106267120A (en) | A kind of Chinese medicine for treating rhinitis preparation and preparation method thereof | |
| CN101028492B (en) | Chinese preparation for treating hysteromyoma | |
| CN101085314A (en) | Chinese patent medicine for treating delayed menstruation | |
| CN100431569C (en) | Chinese medicine prepn for treating dysmenorrhea | |
| CN102133369B (en) | Traditional Chinese medicine composition for treating acute cholecystitis | |
| CN100431592C (en) | Chinese medicinal formulation for treating hyperplasia of prostate | |
| CN100431578C (en) | Preparation of Chinese traditional medicine for treating hyperplasia of prostate | |
| CN100381141C (en) | Chinese medicine for treating prostatic hyperplasia | |
| CN101095907A (en) | Chinese patent drug for treating diabetes peripheral neuritis | |
| CN101129927A (en) | Traditional Chinese medicine composition for treating pelvic inflammatory disease | |
| CN100546617C (en) | A kind of Chinese medicine preparation for the treatment of oviduct obstructive sterility | |
| CN101028421B (en) | Chinese medicine for treating chronic kidney failure | |
| CN102441131A (en) | Chinese medicinal composition for treating traumatic injury | |
| CN100571725C (en) | A kind of Chinese medicine preparation for the treatment of sciatica | |
| CN100450537C (en) | Chinese medicinal formulation for treating prostate hyperplasia | |
| CN101085140A (en) | Medicine for treating preceded menstrual cycle | |
| CN100571747C (en) | A kind of Chinese medicine decoction for the treatment of dysmenorrhea | |
| CN101085249A (en) | Traditional Chinese medicine for treating preceded menstrual cycle | |
| CN101129851A (en) | Traditional Chinese medicine composition for treating hysteromyoma | |
| CN107233505A (en) | It is a kind of to be used to treat pill medicine of constipation and preparation method thereof | |
| CN101095922A (en) | Chinese traditional medicine composition for treating diabetes peripheral neuritis | |
| CN101274027B (en) | Oral medicament, hot administration powder for curing femoral head necrosis | |
| CN101129935A (en) | Proprietary Chinese medicine for treating hysteromyoma | |
| CN101020032A (en) | Chinese medicine prepn for treating ischemic femoral head necrosis | |
| CN101085338A (en) | Traditional Chinese medicine preparation for curing uric acid nephritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: BEIJING SINO-AMERICA INNOVATION UNITED INSTITUTE O Free format text: FORMER OWNER: BEIJING YIXINTANG MEDICINE INST. Effective date: 20111017 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 102300 MENTOUGOU, BEIJING TO: 100076 DAXING, BEIJING |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20111017 Address after: 100076, No. six, No. 10, North East Road, Minsheng Road, fourth village, Xihongmen Town, Beijing, Daxing District Patentee after: Beijing Sino US Joint Institute of innovation and international difficult diseases Address before: Yang Tuo Cun 102300 Beijing city Mentougou District Jun Zhuang Zhen Dong Hospital No. 191 No. 2 Patentee before: Beijing Yixintang Medicine Inst. |
|
| ASS | Succession or assignment of patent right |
Owner name: CHEN YUTANG Free format text: FORMER OWNER: BEIJING SINO-US INNOVATION INSTITUTE OF INTERNATIONAL STUBBORN DISEASES Effective date: 20120316 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Chen Yutang Inventor before: Wang Xinsuo |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: WANG XINSUO TO: CHEN YUTANG |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20120316 Address after: 100076, Beijing Town, Daxing District Town, Xihongmen, four village, Minsheng Road, North East six, No. 10 Patentee after: Chen Yutang Address before: 100076, No. six, No. 10, North East Road, Minsheng Road, fourth village, Xihongmen Town, Beijing, Daxing District Patentee before: Beijing Sino US Joint Institute of innovation and international difficult diseases |
|
| ASS | Succession or assignment of patent right |
Owner name: BEIJING SINO-US INNOVATION UNITED INTERNATIONAL IN Free format text: FORMER OWNER: CHEN YUTANG Effective date: 20120419 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20120419 Address after: 100076, Beijing Daxing District Xihongmen town fourth village Minsheng Road North East six 10, Beijing Sino US Joint Innovation Institute of international difficult disease Chen Zhonghua Dean Patentee after: Beijing Sino US Joint Institute of innovation and international difficult diseases Address before: 100076, Beijing Town, Daxing District Town, Xihongmen, four village, Minsheng Road, North East six, No. 10 Patentee before: Chen Yutang |
|
| ASS | Succession or assignment of patent right |
Owner name: BEIJING CHINESE AND FOREIGN XINCHUANG INTERNATIONA Free format text: FORMER OWNER: BEIJING SINA-AMERICA INNOVATION UNITED INTERNATIONAL DIFFICULT DISEASE RESEARCH INSTITUTE Effective date: 20121017 Owner name: BEIJING SINA-AMERICA INNOVATION UNITED INTERNATION Effective date: 20121017 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100076 DAXING, BEIJING TO: 100012 CHAOYANG, BEIJING |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20121017 Address after: 100012 Beijing city Chaoyang District Shangli Road No. 201 Beijing Chinese New International Medical Research Institute Patentee after: Beijing new China International Pharmaceutical Research Institute Patentee after: Beijing Sino US Joint Institute of innovation and international difficult diseases Address before: 100076, Beijing Daxing District Xihongmen town fourth village Minsheng Road North East six 10, Beijing Sino US Joint Innovation Institute of international difficult disease Chen Zhonghua Dean Patentee before: Beijing Sino US Joint Institute of innovation and international difficult diseases |
|
| ASS | Succession or assignment of patent right |
Owner name: BEIJING JINKUI CHINESE MEDICAL RESEARCH INSTITUTE Free format text: FORMER OWNER: BEIJING CHINESE AND FOREIGN XINCHUANG INTERNATIONAL MEDICAL RESEARCH INSTITUTE Effective date: 20121120 Free format text: FORMER OWNER: BEIJING SINA-AMERICA INNOVATION UNITED INTERNATIONAL DIFFICULT DISEASE RESEARCH INSTITUTE Effective date: 20121120 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Lin Wanshuo Inventor before: Chen Yutang |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100012 CHAOYANG, BEIJING TO: 100010 DONGCHENG, BEIJING Free format text: CORRECT: INVENTOR; FROM: CHEN YUTANG TO: LIN WANSHUO |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20121120 Address after: 100010, No. 3-1, building 3, Beijing Hutong, Dongcheng District, China Patentee after: Beijing Jingui Chinese Medicine Research Institute Co. Ltd. Address before: 100012 Beijing city Chaoyang District Shangli Road No. 201 Beijing Chinese New International Medical Research Institute Patentee before: Beijing new China International Pharmaceutical Research Institute Patentee before: Beijing Sino US Joint Institute of innovation and international difficult diseases |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100421 Termination date: 20200416 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |